Technical Description
The invention introduces a rebamipide transdermal patch designed for treating Parkinson's disease. It involves creating a stable patch using a specific combination of active agents and excipients, including polymers and enhancers.
Problems Addressed
- Slow Drug Absorption
- Plasma Protein Inhibition
- High Dose Frequency
- Invasive Methods
- Limited Bioavailability
Tech Features
- Rebamipide Transdermal Patch
- Effective Against 6-OHDA
- Reduced Dose Frequency
- Non-invasive Drug Delivery
- Enhanced Drug Bioavailability
Target Audience
- Pharmaceutical Industry
- Biomedical Sector
- Healthcare Sector
- Diagnostic Centers
Tech ID: P35–1448 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
